LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer
- PMID: 26721441
- DOI: 10.1016/j.bbrc.2015.12.078
LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer
Abstract
Lactate dehydrogenase-A(LDH-A) is an important rate-limiting enzyme in the Warburg effect. Survival analysis indicated poor clinical outcomes in MIBC with high LDH-A expression. The results of in vitro experiment indicated that LDH-A promotes MIBC cells proliferation, invasion and migration. The positive relationship between LDH-A expression and CSC/EMT markers was confirmed both in invasive bladder cell line and in 136 MIBC specimens. Thus, we conclude that LDH-A may be a promising target for MIBC.
Keywords: E-cadherin; Epithelial-to-mesenchymal transition; Histone deacetylases; Lactate dehydrogenase-A; Muscle-invasive bladder cancer; Oct4.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.Cancer Sci. 2021 Sep;112(9):3822-3834. doi: 10.1111/cas.15047. Epub 2021 Jul 12. Cancer Sci. 2021. PMID: 34181805 Free PMC article.
-
Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.Ann Surg Oncol. 2018 Nov;25(12):3518-3526. doi: 10.1245/s10434-018-6706-0. Epub 2018 Aug 20. Ann Surg Oncol. 2018. PMID: 30128900
-
Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.Int J Radiat Biol. 2016 Jul;92(7):353-63. doi: 10.3109/09553002.2016.1162921. Epub 2016 Mar 24. Int J Radiat Biol. 2016. PMID: 27010533
-
Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Int J Cancer. 2016 Jun 1;138(11):2562-9. doi: 10.1002/ijc.29918. Epub 2015 Nov 23. Int J Cancer. 2016. PMID: 26547270 Review.
-
Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.Mol Cancer Res. 2012 Aug;10(8):995-1009. doi: 10.1158/1541-7786.MCR-12-0274. Epub 2012 Jun 19. Mol Cancer Res. 2012. PMID: 22714124 Review.
Cited by
-
Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect.Cancers (Basel). 2024 Apr 5;16(7):1418. doi: 10.3390/cancers16071418. Cancers (Basel). 2024. PMID: 38611096 Free PMC article.
-
Strategies for Overcoming Immune Evasion in Bladder Cancer.Int J Mol Sci. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105. Int J Mol Sci. 2024. PMID: 38542078 Free PMC article. Review.
-
LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer.J Cancer. 2024 Jan 1;15(3):590-602. doi: 10.7150/jca.86283. eCollection 2024. J Cancer. 2024. PMID: 38213726 Free PMC article.
-
Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer.Front Pharmacol. 2023 Sep 13;14:1215296. doi: 10.3389/fphar.2023.1215296. eCollection 2023. Front Pharmacol. 2023. PMID: 37781694 Free PMC article.
-
Knockdown of PGC1α suppresses dysplastic oral keratinocytes proliferation through reprogramming energy metabolism.Int J Oral Sci. 2023 Sep 4;15(1):37. doi: 10.1038/s41368-023-00242-3. Int J Oral Sci. 2023. PMID: 37661238 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous